Philip O'Reilly

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. ncbi Long-term continuous oxygen treatment in chronic obstructive pulmonary disease: proper use, benefits and unresolved issues
    Philip O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, USA
    Curr Opin Pulm Med 13:120-4. 2007
  2. ncbi Interfering with extracellular matrix degradation to blunt inflammation
    Philip J O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, THT 442, 1530 3rd Avenue South, Birmingham, AL 35294 0006, United States
    Curr Opin Pharmacol 8:242-8. 2008
  3. ncbi N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD
    Philip O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1900 University Blvd, Birmingham, Alabama 35294 0006, USA
    Respir Res 10:38. 2009
  4. ncbi Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
    Philip J O'Reilly
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 5294 0005, USA
    J Neuroimmunol 217:51-4. 2009
  5. ncbi Clinical use of exhaled biomarkers in COPD
    William Bailey
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, AL 35294 0006, USA
    Int J Chron Obstruct Pulmon Dis 2:403-8. 2007
  6. ncbi Recommendations of the 6th long-term oxygen therapy consensus conference
    Dennis E Doherty
    Division of Pulmonary Critical Care, Sleep Medicine, University of Kentucky, Lexington, 40536-0284, USA
    Respir Care 51:519-25. 2006
  7. ncbi National COPD conference summary
    A Sonia Buist
    Oregon Health and Science University, Portland, Oregon, USA
    COPD 1:293-302. 2004
  8. ncbi A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    Donald P Tashkin
    David Geffen School of Medicine at the University of California, Los Angeles 90095 1690, USA
    N Engl J Med 359:1543-54. 2008

Detail Information

Publications8

  1. ncbi Long-term continuous oxygen treatment in chronic obstructive pulmonary disease: proper use, benefits and unresolved issues
    Philip O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, USA
    Curr Opin Pulm Med 13:120-4. 2007
    ..It is important that long-term oxygen treatment be administered only to those patients who will benefit and in a manner that maximizes its efficacy. New studies are urgently needed to address these questions...
  2. ncbi Interfering with extracellular matrix degradation to blunt inflammation
    Philip J O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, THT 442, 1530 3rd Avenue South, Birmingham, AL 35294 0006, United States
    Curr Opin Pharmacol 8:242-8. 2008
    ..Elucidation of these pathways may provide novel biomarkers and therapeutic targets for chronic lung diseases...
  3. ncbi N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD
    Philip O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1900 University Blvd, Birmingham, Alabama 35294 0006, USA
    Respir Res 10:38. 2009
    ..In this study, we investigate if N-alpha-PGP and PGP are biomarkers and potential therapeutic targets for COPD...
  4. ncbi Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
    Philip J O'Reilly
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 5294 0005, USA
    J Neuroimmunol 217:51-4. 2009
    ..This novel, pro-inflammatory role for PE raises the possibility of a self-sustaining pathway of neutrophilic inflammation and may provide biomarkers and therapeutic targets for diseases caused by chronic, neutrophilic inflammation...
  5. ncbi Clinical use of exhaled biomarkers in COPD
    William Bailey
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, AL 35294 0006, USA
    Int J Chron Obstruct Pulmon Dis 2:403-8. 2007
    ..Identification of novel inflammatory mediators in EBC may cast new light on the pathogenesis of COPD and identify new therapeutic targets, which are badly needed in this disease...
  6. ncbi Recommendations of the 6th long-term oxygen therapy consensus conference
    Dennis E Doherty
    Division of Pulmonary Critical Care, Sleep Medicine, University of Kentucky, Lexington, 40536-0284, USA
    Respir Care 51:519-25. 2006
  7. ncbi National COPD conference summary
    A Sonia Buist
    Oregon Health and Science University, Portland, Oregon, USA
    COPD 1:293-302. 2004
    ..This summary provides the recommendations from the conference that will be used to develop an action plan for the US COPD Coalition. It includes actions proposed by plenary speakers, roundtable faculty and conference participants...
  8. ncbi A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    Donald P Tashkin
    David Geffen School of Medicine at the University of California, Los Angeles 90095 1690, USA
    N Engl J Med 359:1543-54. 2008
    ..Previous studies showing that tiotropium improves multiple end points in patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term effects of tiotropium therapy...